Long-Term Real-World Post-approval Safety Data of Multiple Biosimilars from One Marketing-Authorization Holder After More than 18 Years Since Their First Biosimilar Launch

por Sagi, Sreedhar, Anjaneya, Pradeep, Kalsekar, Sameer, Kottke, Andrea, Cohen, Hillel P.
Publicado 2023